アミノグリコシド抗生物質が小さなリボソームサブユニットに結合する:連続電気静止学の調査
Chiansan Ma1, Nathan A Baker, Simpson Joseph
1Department of Chemistry, Yale University, New Haven, Connecticut 06520, USA. chiansan@yale.edu
Journal of the American Chemical Society
|February 14, 2002
まとめ
この研究では,パロモミシン抗生物質が30Sリボソームサブユニットに結合する方法を分析するために,計算式静電学を使用しました. この発見は実験データとよく相関しており,改善されたアミノグリコシド抗生物質を設計するための洞察を提供している.
科学分野:
- 計算化学はコンピュータ化学である.
- 分子生物学は分子生物学である.
- ドラッグ・ディスカバリー・ドラッグ・ディスカバリー
背景:
- パロモミシンなどのアミノグリコシド抗生物質は,細菌感染症の治療に不可欠です.
- 細菌の30Sリボソームサブユニットへの正確な結合メカニズムを理解することは,抗生物質耐性との闘いにとって不可欠です.
研究 の 目的:
- パロモミシンおよび関連する抗生物質が30Sリボソームサブユニットと結束する相互作用を計算的方法を使用して調査する.
- アミノグリコシド結合を制御する静電メカニズムを解明する.
- 新しく,より効果的な抗生物質の合理的な設計のための基礎を提供すること.
主な方法:
- 連続体静電学的方法が採用されました.
- 静電性能を計算するためにプアソン・ボルツマン方程式が解かれた.
- パロモミシン-30Sサブユニット複合体の結晶学的データは構造的なテンプレートとして使用されました.
- 拘束力のあるエネルギー計算のために,表面積に依存するアポラー項が組み込まれました.
主要な成果:
- 計算された結合エネルギーは,実験データと良好な一致を示した.
- リボソーム結合部位の静電ポテンシャルマップが生成されました.
- この研究では,パロモミシン結合に関与する重要な静電相互作用が特定されました.
結論:
- 連続体静電学は,抗生物質とリボソームの相互作用を研究するための信頼できる方法を提供します.
- 静電的要因は,アミノグリコシド抗生物質の結合に重要な役割を果たします.
- この発見は,効果を高める次世代の抗生物質の構造ベースの設計に貴重な洞察を提供します.
関連する概念動画
01:23Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
01:56Riboswitches
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
02:24Ribosome Profiling
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
01:17Gram-negative Bacterial Protein Secretion Systems
Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...